quinoxalinone derivatives (Shandong University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namequinoxalinone derivatives (Shandong University)
Drug Alias Namemulti drug resistance reversal agents (Shandong University)QA-3
ClassificationSmall molecules
Mechanisms of ActionP-glycoprotein 1 inhibitorsApoptosis stimulants
TargetsP-glycoprotein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A